Topical Anti-Inflammatory and Analgesic Effects of Multiple Applications of S(+)-Flurbiprofen Plaster (SFPP) in a Rat Adjuvant-Induced Arthritis Model

Masanori Sugimoto, Yoshihisa Toda, Miyuki Hori, Akiko Mitani, Takahiro Ichihara, Shingo Sekine, Shinsuke Kaku, Noboru Otsuka, Hideo Matsumoto

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

(Table presented.). The aim of this study was to evaluate the efficacy of multiple applications of S(+)-flurbiprofen plaster (SFPP), a novel Nonsteroidal anti-inflammatory drug (NSAID) patch, for the alleviation of inflammatory pain and edema in rat adjuvant-induced arthritis (AIA) model as compared to other NSAID patches. The AIA model was induced by the injection of Mycobacterium butyricum and rats were treated with a patch (1.0 cm × 0.88 cm) containing each NSAID (SFP, ketoprofen, loxoprofen, diclofenac, felbinac, flurbiprofen, or indomethacin) applied to the paw for 6 h per day for 5 days. The pain threshold was evaluated using a flexion test of the ankle joint, and the inflamed paw edema was evaluated using a plethysmometer. cyclooxygenase (COX)−1 and COX-2 inhibition was evaluated using human recombinant proteins. Multiple applications of SFPP exerted a significant analgesic effect from the first day of application as compared to the other NSAID patches. In terms of paw edema, SFPP decreased edema from the second day after application, Multiple applications of SFPP were superior to those of other NSAID patches, in terms of the analgesic effect with multiple applications. These results suggest that SFPP may be a beneficial patch for providing analgesic and anti-inflammatory effects clinically. Drug Dev Res 77 : 206–211, 2016.

Original languageEnglish
Pages (from-to)206-211
Number of pages6
JournalDrug Development Research
DOIs
Publication statusPublished - 2016 Jun 1

Fingerprint

Flurbiprofen
Experimental Arthritis
Non-Steroidal Anti-Inflammatory Agents
Anti-Inflammatory Agents
Edema
Pharmaceutical Preparations
Analgesics
Ketoprofen
Cyclooxygenase 1
Pain Threshold
Ankle Joint
Diclofenac
Cyclooxygenase 2
Mycobacterium
Recombinant Proteins
Indomethacin
Pain
Injections

Keywords

  • analgesic
  • anti-inflammatory
  • NSAIDs
  • S(+)-flurbiprofen

ASJC Scopus subject areas

  • Drug Discovery

Cite this

Topical Anti-Inflammatory and Analgesic Effects of Multiple Applications of S(+)-Flurbiprofen Plaster (SFPP) in a Rat Adjuvant-Induced Arthritis Model. / Sugimoto, Masanori; Toda, Yoshihisa; Hori, Miyuki; Mitani, Akiko; Ichihara, Takahiro; Sekine, Shingo; Kaku, Shinsuke; Otsuka, Noboru; Matsumoto, Hideo.

In: Drug Development Research, 01.06.2016, p. 206-211.

Research output: Contribution to journalArticle

Sugimoto, Masanori ; Toda, Yoshihisa ; Hori, Miyuki ; Mitani, Akiko ; Ichihara, Takahiro ; Sekine, Shingo ; Kaku, Shinsuke ; Otsuka, Noboru ; Matsumoto, Hideo. / Topical Anti-Inflammatory and Analgesic Effects of Multiple Applications of S(+)-Flurbiprofen Plaster (SFPP) in a Rat Adjuvant-Induced Arthritis Model. In: Drug Development Research. 2016 ; pp. 206-211.
@article{8fd1caac7d4c4f5ea752303489fa3a1b,
title = "Topical Anti-Inflammatory and Analgesic Effects of Multiple Applications of S(+)-Flurbiprofen Plaster (SFPP) in a Rat Adjuvant-Induced Arthritis Model",
abstract = "(Table presented.). The aim of this study was to evaluate the efficacy of multiple applications of S(+)-flurbiprofen plaster (SFPP), a novel Nonsteroidal anti-inflammatory drug (NSAID) patch, for the alleviation of inflammatory pain and edema in rat adjuvant-induced arthritis (AIA) model as compared to other NSAID patches. The AIA model was induced by the injection of Mycobacterium butyricum and rats were treated with a patch (1.0 cm × 0.88 cm) containing each NSAID (SFP, ketoprofen, loxoprofen, diclofenac, felbinac, flurbiprofen, or indomethacin) applied to the paw for 6 h per day for 5 days. The pain threshold was evaluated using a flexion test of the ankle joint, and the inflamed paw edema was evaluated using a plethysmometer. cyclooxygenase (COX)−1 and COX-2 inhibition was evaluated using human recombinant proteins. Multiple applications of SFPP exerted a significant analgesic effect from the first day of application as compared to the other NSAID patches. In terms of paw edema, SFPP decreased edema from the second day after application, Multiple applications of SFPP were superior to those of other NSAID patches, in terms of the analgesic effect with multiple applications. These results suggest that SFPP may be a beneficial patch for providing analgesic and anti-inflammatory effects clinically. Drug Dev Res 77 : 206–211, 2016.",
keywords = "analgesic, anti-inflammatory, NSAIDs, S(+)-flurbiprofen",
author = "Masanori Sugimoto and Yoshihisa Toda and Miyuki Hori and Akiko Mitani and Takahiro Ichihara and Shingo Sekine and Shinsuke Kaku and Noboru Otsuka and Hideo Matsumoto",
year = "2016",
month = "6",
day = "1",
doi = "10.1002/ddr.21314",
language = "English",
pages = "206--211",
journal = "Drug Development Research",
issn = "0272-4391",
publisher = "John Wiley and Sons Inc.",

}

TY - JOUR

T1 - Topical Anti-Inflammatory and Analgesic Effects of Multiple Applications of S(+)-Flurbiprofen Plaster (SFPP) in a Rat Adjuvant-Induced Arthritis Model

AU - Sugimoto, Masanori

AU - Toda, Yoshihisa

AU - Hori, Miyuki

AU - Mitani, Akiko

AU - Ichihara, Takahiro

AU - Sekine, Shingo

AU - Kaku, Shinsuke

AU - Otsuka, Noboru

AU - Matsumoto, Hideo

PY - 2016/6/1

Y1 - 2016/6/1

N2 - (Table presented.). The aim of this study was to evaluate the efficacy of multiple applications of S(+)-flurbiprofen plaster (SFPP), a novel Nonsteroidal anti-inflammatory drug (NSAID) patch, for the alleviation of inflammatory pain and edema in rat adjuvant-induced arthritis (AIA) model as compared to other NSAID patches. The AIA model was induced by the injection of Mycobacterium butyricum and rats were treated with a patch (1.0 cm × 0.88 cm) containing each NSAID (SFP, ketoprofen, loxoprofen, diclofenac, felbinac, flurbiprofen, or indomethacin) applied to the paw for 6 h per day for 5 days. The pain threshold was evaluated using a flexion test of the ankle joint, and the inflamed paw edema was evaluated using a plethysmometer. cyclooxygenase (COX)−1 and COX-2 inhibition was evaluated using human recombinant proteins. Multiple applications of SFPP exerted a significant analgesic effect from the first day of application as compared to the other NSAID patches. In terms of paw edema, SFPP decreased edema from the second day after application, Multiple applications of SFPP were superior to those of other NSAID patches, in terms of the analgesic effect with multiple applications. These results suggest that SFPP may be a beneficial patch for providing analgesic and anti-inflammatory effects clinically. Drug Dev Res 77 : 206–211, 2016.

AB - (Table presented.). The aim of this study was to evaluate the efficacy of multiple applications of S(+)-flurbiprofen plaster (SFPP), a novel Nonsteroidal anti-inflammatory drug (NSAID) patch, for the alleviation of inflammatory pain and edema in rat adjuvant-induced arthritis (AIA) model as compared to other NSAID patches. The AIA model was induced by the injection of Mycobacterium butyricum and rats were treated with a patch (1.0 cm × 0.88 cm) containing each NSAID (SFP, ketoprofen, loxoprofen, diclofenac, felbinac, flurbiprofen, or indomethacin) applied to the paw for 6 h per day for 5 days. The pain threshold was evaluated using a flexion test of the ankle joint, and the inflamed paw edema was evaluated using a plethysmometer. cyclooxygenase (COX)−1 and COX-2 inhibition was evaluated using human recombinant proteins. Multiple applications of SFPP exerted a significant analgesic effect from the first day of application as compared to the other NSAID patches. In terms of paw edema, SFPP decreased edema from the second day after application, Multiple applications of SFPP were superior to those of other NSAID patches, in terms of the analgesic effect with multiple applications. These results suggest that SFPP may be a beneficial patch for providing analgesic and anti-inflammatory effects clinically. Drug Dev Res 77 : 206–211, 2016.

KW - analgesic

KW - anti-inflammatory

KW - NSAIDs

KW - S(+)-flurbiprofen

UR - http://www.scopus.com/inward/record.url?scp=84973867626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84973867626&partnerID=8YFLogxK

U2 - 10.1002/ddr.21314

DO - 10.1002/ddr.21314

M3 - Article

C2 - 27241582

AN - SCOPUS:84973867626

SP - 206

EP - 211

JO - Drug Development Research

JF - Drug Development Research

SN - 0272-4391

ER -